Effective January 1, 2017, physicians will report the WATCHMAN implant procedure using the CPT Code 33340. The work relative value unit (RVU) for this code is 14.00 with a total RVU of 23.22. The global period for this code is 0 days.
The WATCHMAN procedure is designated by Medicare as an inpatient only procedure. Therefore, no C- code is assigned to the WATCHMAN Device. C-codes are reported for device-intensive procedures performed in the outpatient hospital site of service.
The code used by physicians to report left atrial appendage closure with implant procedures is 33340. This code has a total RVU value of 23.22 with a work RVU of 14.0, This RVU value correlates to a national average physician payment of approximately $833.
Transesophageal echocardiography (TEE) plays a critical role in visualization and assisting with appropriate candidacy for the WATCHMAN Device. Based on our Directions for Use, the WATCHMAN procedure involves use of TEE imaging as follows:
Prior authorization is a process established by commercial insurance plans that allows a physician to submit a treatment plan prior to surgery. The insurer reviews the treatment plan as well as the patient’s insurance benefits and medical policies to determine if the treatment is covered and the applicable patient responsibility (e.g., coinsurance and/or copay, deductibles, and out-of-pocket amounts). As prior authorization processes vary by insurer, it is important to contact insurance plans and follow their specific requirements.
This information is provided for illustrative purposes only and does not constitute reimbursement or legal advice. Boston Scientific encourages providers to submit accurate and appropriate claims for services. It is always the provider's responsibility to determine medical necessity, the proper site for delivery of any services and to submit appropriate codes, charges, and modifiers for services that are rendered. Boston Scientific recommends that you consult with your payers, reimbursement specialists and/or legal counsel regarding coding, coverage and reimbursement matters. Boston Scientific does not promote the use of its products outside their FDA-approved label.
Boston Scientific is dedicated to providing physicians, allied health professionals and hospitals with world-class programs and services to help advance the standard of patient care and appropriate access to life-enhancing technologies.
Effective January 1, 2017, physicians will report the WATCHMAN implant procedure using the CPT Code 33340. The work relative value unit (RVU) for this code is 14.00 with a total RVU of 23.22. The global period for this code is 0 days.
The WATCHMAN procedure is designated by Medicare as an inpatient only procedure. Therefore, no C- code is assigned to the WATCHMAN Device. C-codes are reported for device-intensive procedures performed in the outpatient hospital site of service.
The code used by physicians to report left atrial appendage closure with implant procedures is 33340. This code has a total RVU value of 23.22 with a work RVU of 14.0, This RVU value correlates to a national average physician payment of approximately $833.
Transesophageal echocardiography (TEE) plays a critical role in visualization and assisting with appropriate candidacy for the WATCHMAN Device. Based on our Directions for Use, the WATCHMAN procedure involves use of TEE imaging as follows:
This information is provided for illustrative purposes only and does not constitute reimbursement or legal advice. Boston Scientific encourages providers to submit accurate and appropriate claims for services. It is always the provider's responsibility to determine medical necessity, the proper site for delivery of any services and to submit appropriate codes, charges, and modifiers for services that are rendered. Boston Scientific recommends that you consult with your payers, reimbursement specialists and/or legal counsel regarding coding, coverage and reimbursement matters. Boston Scientific does not promote the use of its products outside their FDA-approved label.
Boston Scientific is dedicated to providing physicians, allied health professionals and hospitals with world-class programs and services to help advance the standard of patient care and appropriate access to life-enhancing technologies.
When an inpatient hospital WATCHMAN device admission follows a previous inpatient admission for a related or unrelated procedure, readmission policies may apply. A quality review may be triggered and warrant a case review to evaluate combining the inpatient admissions. Each case is specific to clinical circumstances for each admission.
Updates to ICD-10-CM diagnosis codes related to Atrial Fibrillation were announced in the FY 2020 IPPS Final Rule and were effective as of October 1, 2019. Updates are described in CMS 2382, change reques t #114 91.
CMS has certified the LAAO Registry (NCT02699957) as the national registry for data collection for LAAC procedures. The long-term data collection supports CMS’s coverage with evidence development (CED) to ensure better visibility of safety and effectiveness of LAAC procedures.